148 related articles for article (PubMed ID: 38348810)
1. Evaluation of the A
Kyodo A; Nakada Y; Nogi M; Nogi K; Ishihara S; Ueda T; Tohyama T; Enzan N; Ide T; Matsushima S; Tsutsui H; Saito Y
J Am Heart Assoc; 2024 Feb; 13(4):e031104. PubMed ID: 38348810
[TBL] [Abstract][Full Text] [Related]
2. Validation of the MAGGIC (Meta-Analysis Global Group in Chronic Heart Failure) heart failure risk score and the effect of adding natriuretic peptide for predicting mortality after discharge in hospitalized patients with heart failure.
Khanam SS; Choi E; Son JW; Lee JW; Youn YJ; Yoon J; Lee SH; Kim JY; Ahn SG; Ahn MS; Kang SM; Baek SH; Jeon ES; Kim JJ; Cho MC; Chae SC; Oh BH; Choi DJ; Yoo BS
PLoS One; 2018; 13(11):e0206380. PubMed ID: 30485284
[TBL] [Abstract][Full Text] [Related]
3. Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction.
Rørth R; Jhund PS; Yilmaz MB; Kristensen SL; Welsh P; Desai AS; Køber L; Prescott MF; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Packer M; McMurray JJV
Circ Heart Fail; 2020 Feb; 13(2):e006541. PubMed ID: 32065760
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide as biomarkers for heart failure in young children with single ventricle congenital heart disease.
Lowenthal A; Camacho BV; Lowenthal S; Natal-Hernandez L; Liszewski W; Hills NK; Fineman JR; Bernstein HS
Am J Cardiol; 2012 Mar; 109(6):866-72. PubMed ID: 22196786
[TBL] [Abstract][Full Text] [Related]
5. Differential Associations of A-/B-Type Natriuretic Peptides With Cardiac Structure, Function, and Prognosis in Heart Failure.
Tan ESJ; Chan SP; Liew OW; Chong JPC; Gerard Leong KT; Daniel Yeo PS; Ong HY; Jaufeerally F; Sim D; Ling LH; Lam CSP; Richards AM
JACC Heart Fail; 2024 Mar; 12(3):461-474. PubMed ID: 37897459
[TBL] [Abstract][Full Text] [Related]
6. The Molar Ratio of N-terminal pro-B-type Natriuretic Peptide/B-type Natriuretic Peptide for Heart Failure-related Events in Stable Outpatients with Cardiovascular Risk Factors.
Suzuki S; Sugiyama S
Intern Med; 2018 Sep; 57(18):2621-2630. PubMed ID: 29709934
[TBL] [Abstract][Full Text] [Related]
7. Direct comparison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: the Valsartan Heart Failure (Val-HeFT) data.
Masson S; Latini R; Anand IS; Vago T; Angelici L; Barlera S; Missov ED; Clerico A; Tognoni G; Cohn JN;
Clin Chem; 2006 Aug; 52(8):1528-38. PubMed ID: 16777915
[TBL] [Abstract][Full Text] [Related]
8. Simple Risk Score to Predict Survival in Acute Decompensated Heart Failure - A
Nakada Y; Kawakami R; Matsushima S; Ide T; Kanaoka K; Ueda T; Ishihara S; Nishida T; Onoue K; Soeda T; Okayama S; Watanabe M; Okura H; Tsuchihashi-Makaya M; Tsutsui H; Saito Y
Circ J; 2019 Apr; 83(5):1019-1024. PubMed ID: 30842361
[TBL] [Abstract][Full Text] [Related]
9. Impact of increased body mass index on accuracy of B-type natriuretic peptide (BNP) and N-terminal proBNP for diagnosis of decompensated heart failure and prediction of all-cause mortality.
Christenson RH; Azzazy HM; Duh SH; Maynard S; Seliger SL; Defilippi CR
Clin Chem; 2010 Apr; 56(4):633-41. PubMed ID: 20167699
[TBL] [Abstract][Full Text] [Related]
10. [Diagnostic value of the currently used criteria and brain natriuretic peptide for diagnosing congestive heart failure in children with congenital heart disease].
Wu YR; Chen SB; Sun K; Huang MR; Zhang YQ; Chen S
Zhonghua Er Ke Za Zhi; 2006 Oct; 44(10):728-32. PubMed ID: 17229370
[TBL] [Abstract][Full Text] [Related]
11. Hemoglobin and N-terminal pro-brain natriuretic peptide: Independent and synergistic predictors of mortality in patients with acute heart failure Results from the International Collaborative of NT-proBNP (ICON) Study.
Baggish AL; van Kimmenade R; Bayes-Genis A; Davis M; Lainchbury JG; Frampton C; Pinto Y; Richards MA; Januzzi JL
Clin Chim Acta; 2007 Jun; 381(2):145-50. PubMed ID: 17445789
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of the N-terminal pro-brain natriuretic peptide and B-type natriuretic peptide ratio in the acute phase of acute heart failure.
Sawatani T; Shirakabe A; Okazaki H; Matsushita M; Shibata Y; Shigihara S; Otsuka Y; Kiuchi K; Kobayashi N; Hata N; Shimizu W; Asai K
Eur Heart J Acute Cardiovasc Care; 2021 Dec; 10(9):1016-1026. PubMed ID: 34432003
[TBL] [Abstract][Full Text] [Related]
13. Performance of the MAGGIC heart failure risk score and its modification with the addition of discharge natriuretic peptides.
Sawano M; Shiraishi Y; Kohsaka S; Nagai T; Goda A; Mizuno A; Sujino Y; Nagatomo Y; Kohno T; Anzai T; Fukuda K; Yoshikawa T
ESC Heart Fail; 2018 Aug; 5(4):610-619. PubMed ID: 29520978
[TBL] [Abstract][Full Text] [Related]
14. A novel discharge risk model for patients hospitalised for acute decompensated heart failure incorporating N-terminal pro-B-type natriuretic peptide levels: a European coLlaboration on Acute decompeNsated Heart Failure: ELAN-HF Score.
Salah K; Kok WE; Eurlings LW; Bettencourt P; Pimenta JM; Metra M; Bayes-Genis A; Verdiani V; Bettari L; Lazzarini V; Damman P; Tijssen JG; Pinto YM
Heart; 2014 Jan; 100(2):115-25. PubMed ID: 24179162
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide Levels in Heart Failure Patients With and Without Atrial Fibrillation.
Kristensen SL; Jhund PS; Mogensen UM; Rørth R; Abraham WT; Desai A; Dickstein K; Rouleau JL; Zile MR; Swedberg K; Packer M; Solomon SD; Køber L; McMurray JJV;
Circ Heart Fail; 2017 Oct; 10(10):. PubMed ID: 29018174
[TBL] [Abstract][Full Text] [Related]
16. N-Terminal Pro-B-Type Natriuretic Peptide Levels for Risk Prediction in Patients With Heart Failure and Preserved Ejection Fraction According to Atrial Fibrillation Status.
Kristensen SL; Mogensen UM; Jhund PS; Rørth R; Anand IS; Carson PE; Desai AS; Pitt B; Pfeffer MA; Solomon SD; Zile MR; Køber L; McMurray JJV
Circ Heart Fail; 2019 Mar; 12(3):e005766. PubMed ID: 30871349
[TBL] [Abstract][Full Text] [Related]
17. Relationship between anemia, cardiac troponin I, and B-type natriuretic peptide levels and mortality in patients with advanced heart failure.
Ralli S; Horwich TB; Fonarow GC
Am Heart J; 2005 Dec; 150(6):1220-7. PubMed ID: 16338262
[TBL] [Abstract][Full Text] [Related]
18. Anemia considerations when assessing natriuretic peptide levels in ED patients.
Karakoyun I; Colak A; Arslan FD; Hasturk AG; Duman C
Am J Emerg Med; 2017 Nov; 35(11):1677-1681. PubMed ID: 28587950
[TBL] [Abstract][Full Text] [Related]
19. Long-Term Prognostic Significance of Plasma B-Type Natriuretic Peptide Level in Patients With Acute Heart Failure With Reduced, Mid-Range, and Preserved Ejection Fractions.
Hamatani Y; Nagai T; Shiraishi Y; Kohsaka S; Nakai M; Nishimura K; Kohno T; Nagatomo Y; Asaumi Y; Goda A; Mizuno A; Yasuda S; Ogawa H; Yoshikawa T; Anzai T;
Am J Cardiol; 2018 Mar; 121(6):731-738. PubMed ID: 29394996
[TBL] [Abstract][Full Text] [Related]
20. Comparative value of BNP and NT-proBNP in diagnosis of heart failure.
Fonseca C; Sarmento PM; Minez A; Gonçalves E; Covas R; Dias AR; Pina MJ; Ceia F
Rev Port Cardiol; 2004; 23(7-8):979-91. PubMed ID: 15478324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
